You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Neratinib

Showing 1 - 25 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Neratinib
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Metastatic Triple-Negative Breast Carcinoma, Breast Cancer Trial in Dallas (Neratinib Oral Tablet, Ruxolitinib Oral Tablet)

Not yet recruiting
  • Metastatic Triple-Negative Breast Carcinoma
  • Breast Cancer
  • Neratinib Oral Tablet
  • Ruxolitinib Oral Tablet
  • Dallas, Texas
    Baylor University Medical Center, Baylor Charles A Sammons Cance
Aug 22, 2023

NSCLC Trial in Guangzhou (Neratinib tablets)

Not yet recruiting
  • NSCLC
  • Neratinib tablets
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Sep 1, 2023

Metastatic Cancer, HER2 Gene Mutation Trial in Seoul (Neratinib Maleate)

Active, not recruiting
  • Metastatic Cancer
  • HER2 Gene Mutation
  • Neratinib Maleate
  • Seoul, Korea, Republic of
    Korea university Guro hospital
Oct 18, 2023

Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive Trial (Neratinib, Loperamide, Colesevelam)

Not yet recruiting
  • Early-stage Breast Cancer
  • +2 more
  • Neratinib
  • +2 more
  • (no location specified)
Aug 5, 2022

Anatomic Stage I Breast Cancer, Anatomic Stage II Breast Cancer, Anatomic Stage III Breast Cancer Trial in United States

Not yet recruiting
  • Anatomic Stage I Breast Cancer
  • +3 more
  • Endocrine Therapy
  • +7 more
  • Atlanta, Georgia
  • +4 more
Jun 15, 2023

Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +3 more
  • Biopsy
  • +7 more
  • (no location specified)
Nov 9, 2023

Breast Cancer, HER2-positive Breast Cancer Trial in Toronto (Neratinib)

Not yet recruiting
  • Breast Cancer
  • HER2-positive Breast Cancer
  • Neratinib
  • Toronto, Ontario, Canada
    University Health Network: Princess Margaret Cancer Centre
Oct 31, 2022

Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)

Recruiting
  • Metastatic Malignant Solid Neoplasm
  • Unresectable Malignant Solid Neoplasm
  • Biopsy
  • +2 more
  • Boston, Massachusetts
  • +2 more
Jan 25, 2023

Treatment Patterns of Neratinib in HER2+ EBC in China

Not yet recruiting
  • Breast Cancer
  • Neratinib
  • Shanghai, China
    Medical Affair
Aug 4, 2022

Advanced Solid Tumor, Ovarian Cancer Trial in Richmond (Neratinib 160 mg, Neratinib 200 mg, Neratinib 240 mg)

Recruiting
  • Advanced Solid Tumor
  • Ovarian Cancer
  • Neratinib 160 mg
  • +7 more
  • Richmond, Virginia
    Virginia Commonwealth University
May 6, 2022

Breast Cancer Trial (Capecitabine and Neratinib.)

Not yet recruiting
  • Breast Cancer
  • Capecitabine and Neratinib.
  • (no location specified)
Jul 8, 2022

Metastatic Prostate Adenocarcinoma, Castration-resistant Prostate Cancer, Prostate Cancer Trial in Boston (Neratinib)

Terminated
  • Metastatic Prostate Adenocarcinoma
  • +3 more
  • Neratinib
  • Boston, Massachusetts
  • +2 more
Jul 18, 2022

Gastric Cancer Trial in Philadelphia (Neratinib Pill, Fam-Trastuzumab Deruxtecan-Nxki (TDxD))

Suspended
  • Gastric Cancer
  • Neratinib Pill
  • Fam-Trastuzumab Deruxtecan-Nxki (TDxD)
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jul 6, 2022

HER2 Amplified Breast Cancer Trial in Lisboa (Neratinib, Capecitabine, Loperamide)

Completed
  • HER2 Amplified Breast Cancer
  • Neratinib
  • +2 more
  • Lisboa, Portugal
    Hospital CUF Descobertas
Apr 4, 2022

Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Recruiting
  • Breast Cancer
  • +2 more
    • Bouge, Belgium
      Clinique Saint-Luc Bouge
    Oct 25, 2022

    HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,

    Completed
    • HER2-positive Breast Cancer
    • +8 more
    • Neratinib
    • +3 more
    • San Francisco, California
      University of California, San Francisco
    Jan 6, 2023

    Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)

    Active, not recruiting
    • Breast Cancer
    • San Francisco, California
    • +17 more
    Jan 30, 2023

    Solid Tumor, Adult Trial in Richmond (Neratinib, Divalproex Sodium)

    Recruiting
    • Solid Tumor, Adult
    • Neratinib
    • Divalproex Sodium
    • Richmond, Virginia
      Virginia Commonwealth University Massey Cancer Center
    Mar 2, 2022

    HER2-positive Breast Cancer Trial (Neratinib)

    Not yet recruiting
    • HER2-positive Breast Cancer
    • Neratinib
    • (no location specified)
    Nov 29, 2021

    Breast Cancer Trial in United States (Neratinib, Fulvestrant)

    Active, not recruiting
    • Breast Cancer
    • Indianapolis, Indiana
    • +5 more
    Mar 2, 2022

    Breast Cancer, Brain Metastases Trial (Neratinib)

    Withdrawn
    • Breast Cancer
    • Brain Metastases
    • Neratinib
    • (no location specified)
    Feb 28, 2022

    Breast Cancer, HER2-positive Breast Cancer, ER Positive Breast Cancer Trial (Neratinib, Letrozole (L) or Anastrozole (A),

    Not yet recruiting
    • Breast Cancer
    • +3 more
    • Neratinib
    • +2 more
    • (no location specified)
    Jan 11, 2022

    Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

    Recruiting
    • Advanced Malignant Solid Neoplasm
    • +9 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 25, 2022

    Breast Cancer Trial in United States (Capecitabine, Neratinib, EORTC QLQ - BR23, EQ-5D-5L, EORTC QLQ-C30)

    Active, not recruiting
    • Breast Cancer
    • Hartford, Connecticut
    • +9 more
    Apr 15, 2022